Background: Contradictory findings are reported in the literature concerning prognostic factors for failure of non-operative management (NOM) in the treatment of adults with blunt splenic injury. The objective of this systematic review was to identify prognostic factors for failure of NOM, with or without angiography and embolization.
Introduction
Exsanguination caused by abdominal organ injury is one of the main causes of death after trauma. 1 The spleen is the most frequently injured organ in blunt abdominal trauma. 2 Historically, splenectomy was the treatment of choice for traumatic splenic injury. Presently, non-operative management (NOM, e.g. observation) is the standard of care in haemodynamically stable patients. 3 Angiography and embolization (AE) can be used adjacent to NOM. The greatest advantage of a nonoperative management strategy is preservation of splenic function. Success rates of NOM of 78 to 98% have been described in the literature. [4] [5] [6] The presence of multiple injuries, high grade splenic injury, a large hemoperitoneum, contrast extravasation, age above 55 years, and a high Injury Severity Score (ISS) are patient-related factors frequently reported to be associated with failure of NOM. [7] [8] [9] [10] [11] However, data have also been published disputing the increased failure rate in the presence of these factors. [12] [13] [14] [15] [16] Early identification of patients at high risk for failure of NOM is essential since delay in recognition and treatment of late splenic ruptures leads to increased morbidity and mortality. 17, 18 With NOM attempt rates of 90% described in the literature 6 , clear parameters in clinical decision aids are of growing importance. In addition, prognostic risk stratification facilitates adequate resource allocation and allows comparison of outcomes between patients and treatment centers. [19] [20] [21] The aim of this study was therefore to systematically review the literature and identify prognostic factors for failure of NOM, with or without AE for patients with blunt splenic injury.
Patients and Methods

Protocol
No protocol existed for this systematic review.
Search Strategy
We performed a literature search identifying studies reporting on prognostic factors for failure of nonoperative treatment. We chose not to narrow down our search terms because some publications consider embolization a separate treatment entity whereas others accept it as part of NOM. MEDLINE, Embase, and the Cochrane library were searched. No lower limit was set for the date of publication. The literature search was performed with the aid of a clinical librarian according to the Patients, Intervention, Comparison, Outcome (PICO) method. 22 The search strategy is depicted in Appendix 1. A manual and cross-reference search was performed, and the column "related citations" in MEDLINE was screened.
Inclusion and Exclusion Criteria
Randomized controlled trials, prospective or retrospective cohort studies, and cross-sectional studies describing prognostic factors for failure of treatment in adults with blunt splenic injury were eligible for inclusion. Prognostic factors were described as factors that can potentially predict the future course subsequent to disease onset. 23 Case reports or case series, editorial letters or comments, discussions, meeting abstracts, narrative reviews, studies describing (abdominal) organs other than the spleen, studies describing the paediatric population (age < 15 years), animal studies and studies written in a language other then English, French, German, or Dutch were excluded.
Study Selection
Two independent reviewers (C.H.V.D.V. and D.C.O.) simultaneously reviewed titles and abstracts. Articles were included if they compared groups with successful NOM with groups in which NOW failed. After the selection of titles and abstracts, the full text was read to verify if the article met our criteria. Discordance between the reviewers was resolved by discussion.
Risk of Bias
There is no consensus on criteria for assessing methodological quality (currently known as risk of bias) of prognostic studies. 21 We therefore consulted existing checklists and adapted them to our specific study design and subject. [24] [25] [26] [27] Since the majority of the included studies were cohort studies, we developed a checklist aimed at this study design. The checklist consisted of six categories (Appendix 2). All 17 items on the checklist were equally weighed. One point was assigned if the criterion could be answered with "yes". For "no" and "unclear" no points were rewarded. Studies with a final score of 13 (the 75 th percentile) or higher were categorized as high-quality studies. Two reviewers (D.C.O and P.J.) independently assessed risk of bias of all included articles.
Data Extraction
The following features were extracted by two reviewers (D.C.O. and P.J.): risk of bias score, study design, number of included patients, number of patients treated with NOM, definition of NOM and failure of NOM, time to failure, failure rate, relevant information concerning AE, and remarks. Only patient-related prognostic factors that were tested for statistical significance (univariate or multivariate) were used for data extraction.
Best-Evidence Synthesis
We performed a qualitative synthesis of the available evidence (best evidence synthesis 28 ) owing to heterogeneity of study characteristics and methodological quality. Subsequently, we only described high-quality studies. Levels of evidence of the identified prognostic factors were categorized using an adapted ordinal scale previously used in other systematic reviews 27, 29 (Appendix 3).
Statistical Analysis
Main study characteristics were summarized using descriptive statistics. Pooled failure rate of NOM accounting for interstudy variation was analyzed using a nonlinear random effects model, implemented (PROC NLMIXED) in SAS version 9.1 (SAS Institute Inc., Cary, NC). Statistical uncertainty was expressed in 95% confidence intervals (CIs).
Interobserver agreement for assessing risk of bias was analyzed using an intraclass correlation coefficient (PASW Statistics version 18, SPSS Inc., Chicago, IL). We described the prognostic factors and univariate and multivariate statistics as reported by the authors.
Results
Search Strategy and Study Selection
The search strategy was performed in February 2011 (updated in December 2011). The study selection process is depicted in Figure 1 . After exclusion of the duplicates (n = 132). After exclusion of the duplicates (n=132), 335 studies were screened, of which 30 met the inclusion criteria. After addition of 1 crossreference, a total of 31 studies remained. 
Risk of Bias
Median (p25-p75) score for risk of bias was 12 (11) (12) (13) . Interobserver agreement on risk of bias was good (intraclass correlation coefficient of 0.91; 0.82-0.96). Discordance between observers was observed for twenty studies and was resolved through discussion. Ten (32%) studies were categorized as high-quality studies. Almost all studies that were not categorized as high-quality lost points on the same three items (Appendix 2). There were three items on the checklist (Appendix 2) where almost all studies that were not categorized as high quality lost points. In Table 1 a specification is given per study. . In half of the ten high quality studies AE was applied. Pooled failure rate of NOM was 18.4% (95% Cl: 11.5 -28.1). In total, 25 prognostic factors for failure of NOM were tested, of which 14 were statistically significant in one or more studies (only significant factors are presented in the right column of Figure 2 ). Of the 10 studies, 4 performed univariate and multivariate analyses of the data and 6 performed both univariate and multivariate analyses. 12 investigated a small cohort of patients older than 55 years. Mean (SD) age of successfully observed patients was 72 (10) years, as opposed to 60 (4) years for those who failed observation (p < 0.01). Although they concluded that patients with failed observation were significantly younger than patients successfully observed, all patients were older than 55 years. Velmahos 2 17 also demonstrated that patients failing NOM were older (37.5 (13) 31 concluded that patients failing NOM were more likely to be older than 55 years compared with patients successfully treated with NOM (p < 0.01).
Sex
Five studies 9, 30, [32] [33] [34] reported about the relationship between sex and failure of NOM. One study reported a statistically higher amount of men failing NOM (p < 0.01). 32 This effect was only demonstrated in univariate analysis.
Hemoperitoneum
Two studies 9, 30 analyzed the effect of a hemoperitoneum on failure of NOM. One study found a significant relation in univariate analysis (OR, 3.06; 95% CI, 1.00-9.27), but significance was not reached in multivariate logistic regression (adjusted OR, 1.80; 95% CI, 0.47-6.86). 34 demonstrated that splenic injury grade of 3 or higher was significantly associated with failure through univariate and multivariate analyses. Nix et al. 35 compared Grade 2 and 3 injuries ("lower grade") with grade 4 and 5 ("higher grade") in multivariate regression analysis. Higher-grade splenic injuries (adjusted OR, 19.2; 95% CI 7.00-52.62) showed a significantly higher risk of NOM failure compared with lower grade-injuries (adjusted OR, 0.06; 95% CI 0.02-0.14).
Abbreviated Injury Scale Abdomen
Two studies reported about abdominal Abbreviated Injury Scale (AIS) score 17 34 . In the study of Velmahos 2, 17 AIS score of 3 or greater was identified as independent risk factor for failure of NOM (no data presented in the study). Jeremitsky et al. 34 demonstrated a mean (SD) AIS score of the abdomen/ pelvis of 3.9 (0.3) for patients failing NOM versus 2.9 (0.7) for patients treated successfully (p < 0.001). This was confirmed in a Cox regression model (adjusted hazard ratio 1.95; 95% CI, 1.29-2.95).
ISS
Four
12,17,31,34 of the eight 9,12,17,30,31,33-35 studies analyzing ISS found it to be a prognostic factor for failure of NOM. Barone et al. studied the effect of ISS on failure of NOM for patients older than 55 years. 12 The differences in ISS between patients failing observation and successfully observed patients was significant (p = 0.02). Velmahos 2 17 observed higher mean ISSs for patients failing NOM as well (p = 0.02). ISS of 25 or higher was statistically significant in univariate but not in multivariate analysis. Results of the univariate analysis of McIntyre et al. 31 demonstrated that patients who failed NOM were more likely to have an ISS of greater than 25 (p < 0.001). Jeremitsky et al. demonstrated that patients failing NOM had significant higher ISS compared with patients with successful NOM through univariate analysis (p < 0.001). 
TRISS
Both studies 9, 34 analyzing the Trauma and Injury Severity Score (TRISS) found a significant association with failure of NOM. Renzulli et al. 9 demonstrated that TRISS of less than 0.80 was a prognostic factor in univariate analysis (OR, 3.66; 95% CI, 1.16-11.50). Borderline significance was reached in multivariable analysis, but the authors stated that TRISS of less than 0.80 did not significantly effect failure rate. Jeremitsky et al. observed a mean (SD) TRISS of 0.7 (0.4) for patients in whom NOM failed compared with 0.9 (0.2) in successful NOM (p < 0.001) but could not confirm this finding in a multivariate model.
34
Glasgow Coma Scale (GCS)
One 34 of the four articles 9,30,31,34 that reported on Glasgow Coma Scale (GCS) found a significant association with failure. Jeremitsky et al. 34 demonstrated that patients failing NOM had a mean (SD) GCS score of 11.2 (5.3) compared with 13.6 (3.5) for patients with successful NOM (p < 0.001). This was not demonstrated in multivariate analysis.
Systolic Blood Pressure
Systolic Blood Pressure (SBP) was analyzed in eight studies 9, 17, 30, [31] [32] [33] [34] 36 . One study reported that patients in whom NOM failed had significantly lower admission SBP, confirmed by multivariate analysis (adjusted HR, 0.99; 95% CI, 0.90-0.99).
34
Traumatic Brain Injury
One multicenter study found a significant relationship between the effect of traumatic brain injury and failure of NOM in univariate (p = 0.04) and multivariate analysis (adjusted OR, 2.82; 95% CI, 1.14-7.01.
30
Contrast Extravasation
Contrast extravasation on CT, defined as a hyperdense collection of contrast media in the splenic parenchyma, was identified as prognostic factor for failure of NOM by two of the three 30, 32, 36 studies investigating this factor. Velmahos 1 30 stated that contrast extravasation is more frequently present in patients failing NOM compared with patients with successful NOM (p = 0.04). This could not be 100 confirmed through multivariate analysis. Schurr et al. 36 estimated that a patient is 24 times more likely to fail NOM when contrast extravasation is present compared with patients without contrast extravasation (adjusted OR, 24; 95% CI, 3.90-147.43). 17, 34 out of four 9, 17, 33, 34 studies demonstrated a significant relationship between failure of NOM and the number of transfused red blood cells (RBCs) units. According to Velmahos 2, 17 patients with failed NOM received significantly more units of blood while managed nonoperatively compared with patients with successful NOM (p < 0.001). They identified transfusion of more than 1 U of blood as independent risk factor for failure of NOM in logistic regression analysis (HR, 2.66; 95% CI, 1.62-4.37). Jeremitsky et al. 34 concluded that patients who failed NOM were more likely to require blood transfusions compared with those with successful NOM in univariate (p < 0.001) and multivariate analyses (adjusted HR, 2.66; 95% CI, 1.62-4.37).
Number of Transfused Packed Red Blood Cell Units Two
Splenic embolization
Jeremitsky et al. 34 analyzed the effect of splenic embolization on failure of NOM. Multivariate analysis demonstrated that embolization was associated with a decreased risk for failure after adjusting for age, sex, race, blood transfusion at the emergency department, AIS score, history of substance use, and SBP at admission (adjusted HR, 0.18; 95% CI, 0.06-0.55).
Levels of evidence of the identified prognostic factors
Strong evidence exists that age above 40 years old, an ISS of 25 or higher, and splenic injury grade 3 or greater are prognostic factors for failure of NOM. Moderate evidence was available for abdominal AIS score of 3 or greater, TRISS of less than 0.80, the presence of an intraparenchymal contrast blush, and transfusion of more than 1 U of blood. Limited or no evidence was found for the remaining identified prognostic factors ( Table 3) . 
Discussion
The present study systematically reviewed literature on prognostic factors for failure of NOM (observation). Of the 31 included studies, 10 were qualified as high quality. Twenty five prognostic factors were investigated, and 14 were found to significantly affect outcome of NOM. These prognostic factors may assist in the early identification of patients at high risk for failure of NOM, preventing delays in recognition and treatment of late splenic ruptures, which are known to lead to increased resource use, morbidity and mortality. 17, 18 Based on the available evidence, we recommend awareness for failure of NOM in patients aged 40 years or older, patients with splenic injury grade 3 or higher, and patients with an ISS of 25 or higher. Abdominal AIS score of 3 or greater, TRISS of less than 0.80, the presence of an intraparenchymal contrast blush, and an increased transfusion need should a physician to possible failure as well. In the meta-analysis of Bhangu et al., 18 older age (≥55 years) and higher grade (American Association for the Surgery of Trauma Grades 4 or 5) splenic injuries were also identified as predictors for failure. Bhangu et al. 18 additionally identified moderate or large hemoperitoneum as an independent risk factor for failure, although we found only limited evidence for this factor. After Bhangu et al. 18 performed sensitivity analysis of the high-quality studies, higher-grade splenic injuries and the presence of a moderate/large hemoperitoneum remained significantly associated with failure. However, they solely reviewed English language literature and conclusions of their meta-analysis are based on only four studies. A substantial number of included studies consider failure of NOM to be an indication for surgery although a splenectomy for trauma is associated with an increased risk of early infectious complications. 37 Surgery no longer is the only available treatment option in case of failure of NOM. Embolization could be attempted if the patient status allows this approach. Our study was severely limited by the quality of the available studies. No prospective randomized studies were identified, and only one prospective cohort study was available. Another limitation was the amount of heterogeneity throughout the studies: different definitions and cutoff values were used, and study results were based on different sets of prognostic factors, different methods of statistical analysis, and different levels of significance. Another limitation is the translation of a dichotomous outcome to the clinical situation. Should a 41-year-old patient be treated in the same way as a 91-year-old? Although age over 40 years is found to be the best discriminator between success and failure of NOM in the study of Renzulli et al., 9 age over 50 and age over 60 years (OR of 5.78 and 2.32, respectively) were identified as discriminators as well. We think that patients older than 40 years can be managed nonoperatively, but we would like to create awareness for possible failure of NOM in this specific age group. The strength of this review lies in the summary of prognostic factors significantly associated with failure of NOM according to the best evidence. We attempt to offer the physician some practical cutoff points to facilitate the decision-making process. The prognostic factors identified in this review should be confirmed on a large-scale prospective cohort study or in a meta-analysis using individual patient data (IPD) to strengthen the conclusions drawn from this review. IPD reuiqres the gathering of original patient data from original studies and can improve the quality of the data, the analyses, and the reliability of the results. 38 To perform IPD, all authors that published about a topic should be willing to share their data. In addition, unpublished data should be collected. However, this poses a significant challenge.
39
Conclusion
Awareness for failure of NOM is required in patients aged 40 years or older, in patients with an ISS of 25 or higher or those with splenic injury grade 3 or higher. The prognostic factors for failure that we identified should be confirmed in future prospective cohort studies or meta-analyses using IPD. 
